newsfilter
← Latest News
ACCESS Newswire·

HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches

HAVN Life works towards substantiating a patent application and preclinical work VANCOUVER, BC / ACCESSWIRE / May 17, 2021 / HAVN Life Sciences Inc. (CSE:HAVN)(OTC:HAVLF)(FSE:5NP) (the "Company" or "HAVN Life"), a biotechnology company pursuing standard